Meningitis and encephalitis in Poland in 2021.

Q3 Medicine
Karolina Mrozowska-Nyckowska, Jakub Zbrzeźniak, Iwona Paradowska-Stankiewicz
{"title":"Meningitis and encephalitis in Poland in 2021.","authors":"Karolina Mrozowska-Nyckowska, Jakub Zbrzeźniak, Iwona Paradowska-Stankiewicz","doi":"10.32394/pe.77.35","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Meningitis meningitis and/or encephalitis regardless of etiology are subject to monitoring in Poland as part of routine epidemiological surveillance. In this paper, meningitis and/or encephalitis in 2021 caused by Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and tick-borne encephalitis virus are discussed in detail. In Poland, immunoprophylaxis in the form of mandatory or recommended vaccinations is used to prevent diseases caused by the aforementioned etiological agents.</p><p><strong>Aim of the study: </strong>The aim of this study was to assess the epidemiological incidence of meningoencephalitis and encephalitis in Poland, in 2021 including analysis of the impact of the COVID-19 pandemic.</p><p><strong>Material and methods: </strong>To analyse the epidemiological situation of neuroinfections in Poland, we used data sent to NIPH NIH - NRI by Voivodeship Sanitary and Epidemiological Stations and published in the annual bulletin: \"Infectious diseases and poisonings in Poland in 2021\" and \"Protective vaccination in Poland in 2021\" as well as individual epidemiological interviews recorded in the EpiBase system.</p><p><strong>Results: </strong>In 2021, a total of 973 cases of meningitis and/or encephalitis were registered in Poland. This is a 16.1% increase in the number of cases compared to 2020, but still a 57% decrease in the number of cases compared to 2019 when 2,249 cases were recorded. For infections of bacterial etiology, including cases of neuroborreliosis, the number of cases increased by 38.3% (from 376 to 520, incidence from 0.96 to 1.76 per 100,000). Compared to 2020 and 2019, the incidence of meningitis and/or encephalitis of N. meningitidis decreased by 10.7% (from 0.13 to 0.15) and 47.4% (from 0.25 to 0.13), respectively, and for H. influenzae by 75% (from 0.01 to 0.03) and 70% (from 0.01 to 0.03). For S. pneumoniae, we can speak of an increase in incidence against 2020 of 57.1% (121 vs 77 cases, incidence 0.32 vs 0.20) and a decrease against 2019. (121 vs 190, incidence 0.32 vs 0.47). Infections of viral etiology accounted for 47% of all registered cases. There was a slight decrease in their number, by 2% (from 462 to 453 cases). In addition, there was an increase in cases of tick-borne encephalitis, from 158 in 2020 to 210 in 2021 (an increase of 32.9%), and a decrease in cases from 265 in 2019 (a decrease of 20.8%).</p><p><strong>Summary and conclusions: </strong>2021 showed an overall upward trend in the number of recorded cases of bacterial meningitis and/or encephalitis, and a slight decrease in the number of viral meningitis and/or encephalitis cases compared to 2020. Still, the observed number of meningitis and/or encephalitis cases in 2021, both bacterial and viral incidences, remains below the levels observed in the pre-pandemic COVID-19 period (2019). As a result of the SARS-CoV-2 outbreak, the introduction of measures to limit the transmission of the SARS-CoV-2 virus has been observed to reduce the spread of other droplet- and airborne pathogens, thus also pathogens such as S. pneumoniae, H.influenzae and N. menningitidis.</p>","PeriodicalId":20777,"journal":{"name":"Przeglad epidemiologiczny","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad epidemiologiczny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32394/pe.77.35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Meningitis meningitis and/or encephalitis regardless of etiology are subject to monitoring in Poland as part of routine epidemiological surveillance. In this paper, meningitis and/or encephalitis in 2021 caused by Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and tick-borne encephalitis virus are discussed in detail. In Poland, immunoprophylaxis in the form of mandatory or recommended vaccinations is used to prevent diseases caused by the aforementioned etiological agents.

Aim of the study: The aim of this study was to assess the epidemiological incidence of meningoencephalitis and encephalitis in Poland, in 2021 including analysis of the impact of the COVID-19 pandemic.

Material and methods: To analyse the epidemiological situation of neuroinfections in Poland, we used data sent to NIPH NIH - NRI by Voivodeship Sanitary and Epidemiological Stations and published in the annual bulletin: "Infectious diseases and poisonings in Poland in 2021" and "Protective vaccination in Poland in 2021" as well as individual epidemiological interviews recorded in the EpiBase system.

Results: In 2021, a total of 973 cases of meningitis and/or encephalitis were registered in Poland. This is a 16.1% increase in the number of cases compared to 2020, but still a 57% decrease in the number of cases compared to 2019 when 2,249 cases were recorded. For infections of bacterial etiology, including cases of neuroborreliosis, the number of cases increased by 38.3% (from 376 to 520, incidence from 0.96 to 1.76 per 100,000). Compared to 2020 and 2019, the incidence of meningitis and/or encephalitis of N. meningitidis decreased by 10.7% (from 0.13 to 0.15) and 47.4% (from 0.25 to 0.13), respectively, and for H. influenzae by 75% (from 0.01 to 0.03) and 70% (from 0.01 to 0.03). For S. pneumoniae, we can speak of an increase in incidence against 2020 of 57.1% (121 vs 77 cases, incidence 0.32 vs 0.20) and a decrease against 2019. (121 vs 190, incidence 0.32 vs 0.47). Infections of viral etiology accounted for 47% of all registered cases. There was a slight decrease in their number, by 2% (from 462 to 453 cases). In addition, there was an increase in cases of tick-borne encephalitis, from 158 in 2020 to 210 in 2021 (an increase of 32.9%), and a decrease in cases from 265 in 2019 (a decrease of 20.8%).

Summary and conclusions: 2021 showed an overall upward trend in the number of recorded cases of bacterial meningitis and/or encephalitis, and a slight decrease in the number of viral meningitis and/or encephalitis cases compared to 2020. Still, the observed number of meningitis and/or encephalitis cases in 2021, both bacterial and viral incidences, remains below the levels observed in the pre-pandemic COVID-19 period (2019). As a result of the SARS-CoV-2 outbreak, the introduction of measures to limit the transmission of the SARS-CoV-2 virus has been observed to reduce the spread of other droplet- and airborne pathogens, thus also pathogens such as S. pneumoniae, H.influenzae and N. menningitidis.

2021 年波兰的脑膜炎和脑炎。
导言:作为常规流行病学监测的一部分,波兰对脑膜炎和/或脑炎(无论其病因)进行监测。本文将详细讨论2021年由脑膜炎奈瑟菌、肺炎链球菌、流感嗜血杆菌和蜱传脑炎病毒引起的脑膜炎和/或脑炎。在波兰,通过强制或建议接种疫苗的形式进行免疫预防,以预防上述病原体引起的疾病:本研究旨在评估 2021 年波兰脑膜脑炎和脑炎的流行病学发病率,包括分析 COVID-19 大流行的影响:为了分析波兰神经感染的流行病学状况,我们使用了各省卫生和流行病学站发送给 NIPH NIH - NRI 并在年度公报中公布的数据:"2021 年波兰的传染病和中毒事件 "和 "2021 年波兰的保护性疫苗接种",以及 EpiBase 系统中记录的个人流行病学访谈:2021年,波兰共登记了973例脑膜炎和/或脑炎病例。与2020年相比,病例数增加了16.1%,但与2019年记录的2249例病例相比,病例数仍减少了57%。至于细菌病因感染,包括神经源性疾病病例,病例数增加了38.3%(从376例增加到520例,发病率从每10万人中0.96例增加到1.76例)。与2020年和2019年相比,脑膜炎奈瑟菌脑膜炎和/或脑炎的发病率分别下降了10.7%(从0.13降至0.15)和47.4%(从0.25降至0.13),流感嗜血杆菌的发病率分别下降了75%(从0.01降至0.03)和70%(从0.01降至0.03)。肺炎双球菌的发病率与 2020 年相比增加了 57.1%(121 例 vs 77 例,发病率 0.32 vs 0.20),与 2019 年相比有所下降(121 例 vs 190 例,发病率 0.32 vs 0.20)。(121 例对 190 例,发病率为 0.32 对 0.47)。病毒感染占所有登记病例的 47%。其数量略有下降,降幅为 2%(从 462 例降至 453 例)。此外,蜱传脑炎病例从2020年的158例增加到2021年的210例(增加了32.9%),病例数则从2019年的265例减少到2021年的210例(减少了20.8%):与2020年相比,2021年记录在案的细菌性脑膜炎和/或脑炎病例数总体呈上升趋势,病毒性脑膜炎和/或脑炎病例数略有下降。不过,2021 年观察到的脑膜炎和/或脑炎病例数,包括细菌和病毒发病率,仍低于 COVID-19 流行前(2019 年)观察到的水平。由于 SARS-CoV-2 的爆发,采取了限制 SARS-CoV-2 病毒传播的措施,从而减少了其他飞沫和空气传播病原体的传播,因此也减少了肺炎球菌、流感嗜血杆菌和脑膜炎双球菌等病原体的传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Przeglad epidemiologiczny
Przeglad epidemiologiczny Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
64
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信